loader
Please Wait
Applying Filters...

Information, Expiry & Status of Health Canada Patents covering Delavirdine.

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2GlaxoSmithKline Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Discovery on Target
Not Confirmed
arrow
Discovery on Target
Not Confirmed

Delavirdine

Brand Name : RESCRIPTOR

Patent Number : 2071529

Filing Date : 1990-12-24

Strength per Unit : 100 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-12-24

Date Granted : 2001-03-20

blank

02

arrow
Discovery on Target
Not Confirmed
arrow
Discovery on Target
Not Confirmed

Delavirdine

Brand Name : RESCRIPTOR

Patent Number : 2184598

Filing Date : 1995-03-01

Strength per Unit : 100 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2015-03-01

Date Granted : 2005-05-03

blank